2 Growth Stocks Ready to Profit From Cannabis 2.0

The combination of Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) looks like a winning bet.

| More on:

In October, the cannabis game changed forever, even if many pot investors weren’t paying attention. That month, Canada legalized an entire host of new marijuana categories, the most exciting of which included new edibles and beverages.

These form factors could eventually double or triple the size of the Canadian cannabis market. Analysts are calling this emerging opportunity “Cannabis 2.0.”

The opportunity is still in its early stages, however. If you’re paying attention, you could capitalize at bargain prices. If growth tracks as expected, some stock prices could go exponential.

Only one thing matters

If you want to capitalize on new consumables categories like beverages and edibles, it helps to look at what’s worked in other markets. The biggest thing a company can do to achieve massive success in consumer markets is to create a renowned brand.

There’s a reason why Coca-Cola Co and PepsiCo, Inc. are worth a combined $500 billion. McDonald’s Corp is worth more than $150 billion, while Kraft Heinz Co is worth $40 billion. Above all else, consumers buy what they know and trust.

The same behaviour will be applied to cannabis consumables. Would you rather buy a cannabis product from a brand you already love or from a company you’ve never heard of? Trust will play a major role in purchasing decisions, especially when it comes to new cannabis users.

This stock can win

Few cannabis companies are willing to admit that they need help from existing brands. Only one company has accepted this weakness, opting instead to partner with globally recognized brands with high levels of consumer recognition. That company is Hexo Corp (TSX:HEXO)(NYSE:HEXO).

Rather than creating its own pot brands from scratch, Hexo is leveraging brands that already have decades of consumer trust and billions of dollars in ad spending.

Here’s a perfect example. In October of 2019, THC-infused beverages were made legal in Canada. Within months, Hexo was able to get its first pot-based drinks to market.

These drinks will be marketed under one of Canada’s most trusted drink brands. How was it able to achieve this?

In 2018, Hexo created a joint venture with Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP), which has decades of experience and brand recognition.

Over the next 12 months, the companies combined their manufacturing capabilities to design and co-create marijuana-based drinks. When legalization occurred, the joint venture was able to beat all others to market.

Ask yourself one question: Will Canadian’s be more likely to buy a Molson Coors cannabis drink, or a cannabis drink from an unknown competitor?

The answer should be clear. When it comes to competing in this rapidly emerging category, the Hexo-Molson tie-up is lightyears ahead of the competition.

Globally, alcohol sales reached $1.4 trillion in 2019. How big could cannabis drink sales get? Virtually no one is paying attention to this opportunity.

Hexo is expected to generate just $80 million in sales this year. Molson, meanwhile, is expected to earn roughly $13 billion in revenue. The cannabis opportunity could have game-changing results for both companies.

If cannabis beverage demand growth becomes even a small fraction of alcohol demand, this category could add billions in sales for both Hexo and Molson.

That’s an opportunity the market isn’t pricing in. By getting in before sales traction hits, however, you can execute on this year’s best pot trade.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »